MicroRNAs as tumour suppressors in canine and human melanoma cells and as a prognostic factor in canine melanomas

Veterinary and Comparative Oncology

Volumn 11, Issue 2, 2013, Pages 113-123

  Noguchi, S ^a   Mori, T ^a   Hoshino, Y ^a   Yamada, N ^a   Maruo, K ^a   Akao, Y ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Anti oncomir; ERBB3; Malignant melanoma; miRNA 203; miRNA 205; Prognostic factor

Indexed keywords

MESSENGER RNA; MICRORNA;

ANIMAL; ARTICLE; DOG; DOG DISEASE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DOG DISEASES; DOGS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MICRORNAS; RNA, MESSENGER;

EID: 84877329406     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1002/vco.306     Document Type: Article

References (31)

1. Miller AJ and Mihm MC Jr. Melanoma. New England Journal of Medicine 2006; 355: 51-65.
2. th edn., SJ Withrow and DM Vail, eds., Philadelphia, Saunders, 2007:455-475.
3. Liao JC, Gregor P, Wolchok JD, Orlandi F, Craft D, Leung C, Houghton AN and Bergman PJ. Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma. Cancer Immunology 2006; 6: 8.
4. MacEwen EG, Patnaik AK, Harvey HJ, Hayes AA and Matus R. Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Investigation 1986; 4: 397-402.
5. Bergman PJ. Canine oral melanoma. Clinical Techniques in Small Animal Practice 2007; 22: 55-60.
6. Paoloni M and Khanna C. Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer 2008; 8: 147-156.
7. Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA, Spandidos DA, Stivala F and Malaponte G. Melanoma: molecular pathogenesis and emerging target therapies [Review]. International Journal of Oncology 2009; 34: 1481-1489.
8. Eggermont AM and Robert C. New drugs in melanoma: it's a whole new world. European Journal of Cancer 2011.
9. Cowland JB, Hother C and Gronbaek K. MicroRNAs and cancer. APMIS 2007; 115: 1090-1106.
10. Zhang B, Pan X, Cobb GP and Anderson TA. microRNAs as oncogenes and tumor suppressors. Developmental Biology 2007; 302: 1-12.
11. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
12. Mortarino M, Gioia G, Gelain ME, Albonico F, Roccabianca P, Ferri E and Comazzi S. Identification of suitable endogenous controls and differentially expressed microRNAs in canine fresh-frozen and FFPE lymphoma samples. Leukemia Research 2010; 34: 1070-1077.
13. Gioia G, Mortarino M, Gelain ME, Albonico F, Ciusani E, Forno I, Marconato L, Martini V and Comazzi S. Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia. Veterinary Immunology and Immunopathology 2011; 142: 228-235.
14. Boggs RM, Wright ZM, Stickney MJ, Porter WW and Murphy KE. MicroRNA expression in canine mammary cancer. Mammalian Genome 2008; 19: 561-569.
15. Inoue K, Ohashi E, Kadosawa T, Hong SH, Matsunaga S, Mochizuki M, Nishimura R and Sasaki N. Establishment and characterization of four canine melanoma cell lines. Journal of Veterinary Medical Science 2004; 66: 1437-1440.
16. miRBase (2011) http://www.mirbase.org/index.shtml [accessed 6 July 2011].
17. Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, Naoe T and Akao Y. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Letters 2011; 307: 211-220.
18. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL and Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-152.
19. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL and Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Research 2007; 67: 6130-6135.
20. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Menard S, Croce CM and Tagliabue E. microRNA-205 regulates HER3 in human breast cancer. Cancer Research 2009; 69: 2195-2200.
21. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-776.
22. Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B and Zhu Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Letters 2010; 298: 50-63.
23. Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM and Breakefield XO. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Molecular and Cellular Biology 2009; 29: 5923-5940.
24. Wu H, Zhu S and Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Research 2009; 19: 439-448.
25. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, Biffoni M, Felli N, Mattia G, Petrini M, Colombo MP, Peschle C and Caré A. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Research 2008; 68: 2745-2754.
26. Schultz J, Lorenz P, Gross G, Ibrahim S andKunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Research 2008; 18: 549-557.
27. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I and Hernando E. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 1814-1819.
28. Segura MF, Belitskaya-Levy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman I and Hernando E. Melanoma MicroRNA signature predicts post-recurrence survival. Clinical Cancer Research 2010; 16: 1577-1586.
29. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V and Kashani-Sabet M. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. Journal of Biological Chemistry 2011; 286: 16606-16614.
30. HMDD (2011) http://202.38.126.151/hmdd/mirna/md/[accessed 6 July 2011].
31. Buac K, Xu M, Cronin J, Weeraratna AT, Hewitt SM and Pavan WJ. NRG1/ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation. Pigment Cell and Melanoma Research 2009; 22: 773-784.